Vicarious Surgical (NYSE:RBOT) announced today that it successfully completed an in-vivo porcine lab as it advances its ...
The December in-vivo lab builds on Vicarious Surgical's disciplined, specification-driven development approach and reflects the company's focus on minimizing technical risk through iterative testing, ...
Zacks Investment Research on MSN
RBOT enters strategic software partnership to streamline development
Vicarious Surgical Inc.RBOT recently announced a software execution partnership with a global digital engineering and ...
Vicarious Surgical Inc. (NYSE: RBOT) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that it has entered into a ...
Under the agreement, the engineering partner will be responsible for a significant portion of the software development for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback